Back to News
Market Impact: 0.2
Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
Parse Biosciences and Nomic Bio partnered on Cascade, a dataset pairing RNA and protein data across 100 million cells. The companies say it is intended to accelerate immune drug-target discovery; the announcement provides no reported results or financial terms.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Stocks slump, bonds leap as AI giants’ spending spooks investors
- PC chip plunge wipes out a quarter of Intel’s value
- Daiichi Sankyo’s first-half profit rises on cancer drug growth; shares up
- Intel plunges on a major guidance miss. What went wrong — and how to proceed
- Japan’s Nikkei slumps 3% as tech stocks tumble on AI worries
- Starbucks serves up a solid quarter and full-year outlook. Why we're staying invested